Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

Market Cap	10.06B
Revenue (ttm)	3.00B
Net Income (ttm)	532.43M
Shares Out	477.87M
EPS (ttm)	1.12
PE Ratio	18.74
Forward PE	15.83
Dividend	0.40 (1.90%)
Ex-Dividend Date	May 20, 2025

Volume	4,823,338
Average Volume	4,619,314
Open	21.60
Previous Close	21.05
Day's Range	21.00 - 21.60
52-Week Range	19.20 - 31.50
Beta	1.19
RSI	43.20
Earnings Date	Aug 14, 2025

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provide...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 3,197
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300482

Financial Performance

In 2024, SHE:300482's revenue was 3.06 billion, an increase of 10.85% compared to the previous year's 2.76 billion. Earnings were 561.63 million, an increase of 15.18%.